drugset / Trial / NCT06647628
A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005)
RandomizedSequentialTriple-blindBasic science
Summary
The purpose of this study is to learn about the safety of MK-1708, and how well elderly people tolerate it. The study will also measure what happens to MK-1708 in a healthy elderly person's body over time (pharmacokinetic or PK study). Researchers will learn if at least 1 dose level of MK-1708 will be safe, well-tolerated, and will be above a certain level in people's blood after 24 hours.
Timeline
- Start
- 2024-11-04
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-1708 | Unknown | — | Oral |
Indications
No indication recorded.